Wearable Eye Therapy Frame for Home Macular Degeneration Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for dry macular degeneration are ineffective, and existing devices for photobiomodulation and pulsed electromagnetic therapy are large and expensive, requiring patients to receive treatments at medical facilities, making them inconvenient and inaccessible for frequent sessions.
Innovation Solution
A portable, wearable device combining photobiomodulation, pulsed electromagnetic therapy, and bio-resonance that can be used at home or work, featuring a light source and pulsed electromagnetic field emitter, emitting specific wavelengths and frequencies to stimulate retinal healing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If treatments are administered at medical facilities using existing devices, then treatment effectiveness is maintained, but patient convenience and accessibility deteriorate due to large device size and high cost
Solution Approach 1:
The device is segmented into modular components: a frame (glasses structure), light sources integrated into the frame, and electromagnetic field emitters positioned near the eyes. This segmentation allows the treatment system to be distributed across wearable components rather than requiring a single large medical facility device.
Solution Approach 2:
The patent creates a portable copy of the medical facility treatment system by integrating scaled-down light sources and electromagnetic field emitters into a wearable frame, replicating the therapeutic functions in a compact form factor that can be used at home.
2Productivity
If frequent treatment sessions are required, then treatment effectiveness improves, but patient accessibility deteriorates due to the need for medical facility visits
Solution Approach 1:
The device enables patients to self-administer treatment at home without requiring medical professional intervention. The frame with integrated light sources and electromagnetic field emitters allows the patient to receive therapy independently, eliminating the need for scheduled medical facility appointments.
Solution Approach 2:
The device is designed to be worn and activated by the patient themselves, preparing and delivering treatment in advance without requiring repeated visits to medical facilities. The preliminary design consideration of making it wearable enables immediate and frequent use.
3Adaptability or versatility
If standard treatments are used for wet macular degeneration, then some treatment options are available, but treatment effectiveness deteriorates due to lack of standardized effective protocols
Solution Approach 1:
The device combines multiple therapeutic modalities into a single system: photobiomodulation through various light sources (yellow, red, deep red, near-infrared) and pulsed electromagnetic field therapy. This multi-functional approach addresses different aspects of macular degeneration treatment in one integrated device.
Solution Approach 2:
The device utilizes specific wavelength parameters for different light sources (yellow: 580-600nm, red: 620-640nm, deep red: 720-760nm, near-infrared: 860-900nm) and specific electromagnetic field frequencies to optimize treatment effectiveness for different aspects of retinal healing and protection.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device provides effective, non-invasive treatment for dry macular degeneration and other eye disorders, allowing patients to conveniently administer therapy independently, with preliminary results indicating successful treatment outcomes.
Implementation Method 1
a light source and a pulsed electromagnetic field emitter connected to a frame, wherein the frame can position the light source to emit light into an eye
Implementation Method 2
a pulsed electromagnetic field emitter capable emitting a magnetic frequency from about 2.58 Hz to about 100 Hz or about 2 μT to about 100 μT
Data Source
AI summary
The present disclosure relates to devices for treating eye disorders, such as macular degeneration, with electromagnetic pulses and/or photobiomodulation. Examples of the devices, include wearable, portable, or mobile devices, which include a light source and a pulsed electromagnetic field emitter that are connected to or capable of connecting to a frame, such as an eye wear. Benefits of the devices disclosed herein can include a device for treating eye disorders, which can be self-administered by a patient or subject at home, at work, or during travel.